TY - JOUR
PY - 2021//
TI - Poisoning during the COVID-19 outbreak and lockdown: retrospective analysis of exposures reported to French poison control centres
JO - Clinical toxicology (Philadelphia, Pa.)
A1 - Le Roux, Gaël
A1 - Sinno-Tellier, Sandra
A1 - Puskarczyk, Emmanuel
A1 - Labadie, Magali
A1 - von Fabeck, Katharina
A1 - Pelissier, Fanny
A1 - Nisse, Patrick
A1 - Paret, Nathalie
A1 - Descatha, Alexis
A1 - Vodovar, Dominique
SP - ePub
EP - ePub
VL - ePub
IS - ePub
N2 - INTRODUCTION: The aim was to assess the impact of the COVID-19 pandemic on French Poison Control Centre (PCC) call characteristics.
METHODS: Reported cases of xenobiotic exposures from 1 March to 30 April in 2018, 2019, and 2020 were extracted from the French National Database of Poisonings. The collected data included call, patient, and exposure characteristics for both general calls and for calls involving sentinel xenobiotic categories related to the COVID-19 pandemic. The 2020 exposures were compared to 2018-2019 exposures by using simple logistic models in order to provide effect size with odds ratios.
RESULTS: From March to April 2020, 32,182 exposures were reported to French PCCs with an overall increase of 5.6% compared to exposures in the same time frame in 2018-2019. A similar increase in calls was observed in non-epidemic and epidemic COVID-19 areas with an increase in calls from the public (+13.6%) while calls from health-professionals decreased (-7.5%). Despite the increase in exposures, the incidence of symptomatic exposures remained stable (-0.4%) with a decrease in severity (moderate/severe -17.2%). A significant increase in exposures to home cleaning products containing biocides, essential oils, and alcohol-based hand sanitizers (odds ratio >1.3, p < .0001) was observed.
DISCUSSION AND CONCLUSION: The COVID-19 pandemic altered calls to French PCCs with a small increase in calls during the study period and changes in the pattern of exposure. These changes possibly reflected the indirect consequences of the COVID-19 pandemic i.e., limited access to primary care, fear of contracting COVID-19 and anxiety related to home isolation.
Language: en
LA - en SN - 1556-3650 UR - http://dx.doi.org/10.1080/15563650.2021.1874402 ID - ref1 ER -